EdiGene snags $15 mln Series B

EdiGene, an emerging biotechnology company focused on treating genetic disorders, has raised $15 million in Series B funding. The investors included UTokyo Innovation Platform, SBI Investment, Fast Track Initiative, SMBC Venture Capital, Mizuho Capital and CareNet Group.

Source: Press Release